# The Effect of Novel D3 Use as a Mouthwash in COVID-19 Patients

> **NCT07068282** · PHASE1 · COMPLETED · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 25 (actual)

## Conditions studied

- Corona Virus Disease 19 (COVID-19)

## Interventions

- **DRUG:** Cholecalciferol (vitaminD3)

## Key facts

- **NCT ID:** NCT07068282
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-24
- **Primary completion:** 2025-01-25
- **Final completion:** 2025-02-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07068282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07068282, "The Effect of Novel D3 Use as a Mouthwash in COVID-19 Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07068282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*